These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 7463046

  • 1. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR, Watanabe M, Seeman P.
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [Abstract] [Full Text] [Related]

  • 3. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW, Leff SE, Creese I.
    Biochem Pharmacol; 1984 Mar 15; 33(6):877-87. PubMed ID: 6712712
    [Abstract] [Full Text] [Related]

  • 4. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2973-7. PubMed ID: 6626267
    [Abstract] [Full Text] [Related]

  • 5. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK.
    Mol Pharmacol; 1988 Apr 01; 33(4):402-13. PubMed ID: 3357484
    [Abstract] [Full Text] [Related]

  • 6. Effects of proteolytic enzymes and monovalent ions demonstrate protease-sensitive and protease-insensitive stereospecific binding sites on dopaminergic receptors in rat striatum.
    Leysen JE, Van Gompel P.
    Biochem Pharmacol; 1982 Apr 01; 31(7):1343-55. PubMed ID: 7046754
    [Abstract] [Full Text] [Related]

  • 7. Biochemical properties of spiperone binding to rat brain membranes.
    Sundermann RH, Wooten GF.
    Pharmacology; 1980 Apr 01; 21(4):295-305. PubMed ID: 6106952
    [Abstract] [Full Text] [Related]

  • 8. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR, Molinoff PB.
    Mol Pharmacol; 1983 Mar 01; 23(2):303-9. PubMed ID: 6835199
    [Abstract] [Full Text] [Related]

  • 9. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 10. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
    Bacopoulos NG.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3085-91. PubMed ID: 7150335
    [Abstract] [Full Text] [Related]

  • 11. Guanine nucleotides do not inhibit tritiated dopamine agonist binding to bovine striatal membranes.
    Near JA, Mahler HR.
    Neurochem Res; 1982 Jul 01; 7(7):831-7. PubMed ID: 7121724
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA, Altar CA, Wong CA, Marshall JF.
    Brain Res; 1984 Jun 04; 302(1):9-18. PubMed ID: 6428705
    [Abstract] [Full Text] [Related]

  • 13. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR, Weinberger S, Segal DS, Creese I.
    Experientia; 1982 Oct 15; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract] [Full Text] [Related]

  • 14. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL, Largent BL, Snyder SH.
    Life Sci; 1984 Nov 05; 35(19):1981-8. PubMed ID: 6149442
    [Abstract] [Full Text] [Related]

  • 15. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
    Scheuhammer AM, Cherian MG.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3405-13. PubMed ID: 3931643
    [Abstract] [Full Text] [Related]

  • 16. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD, Jenner P, Kelly E, Marsden CD.
    Br J Pharmacol; 1983 Jun 01; 79(2):599-610. PubMed ID: 6418246
    [Abstract] [Full Text] [Related]

  • 17. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN.
    Gen Pharmacol; 1983 Jun 01; 14(6):609-14. PubMed ID: 6141122
    [Abstract] [Full Text] [Related]

  • 18. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain.
    Gundlach AL, McDonald D, Beart PM.
    J Neurochem; 1982 Sep 01; 39(3):890-4. PubMed ID: 7097294
    [Abstract] [Full Text] [Related]

  • 19. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
    Sibley DR, Creese I.
    Endocrinology; 1980 Nov 01; 107(5):1405-9. PubMed ID: 7428676
    [Abstract] [Full Text] [Related]

  • 20. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I, Snyder SH.
    Eur J Pharmacol; 1979 Jun 15; 56(3):277-81. PubMed ID: 38973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.